Moreover, our results also demonstrate that the type II interferon IFN-γ, which is mediated by IRF-1, can attenuate MIR17HG expression in GC cells and therefore further links the tumour immune response to cancer cell metastasis. This evidence concerns the gene IRF1 and neoplasm.